ID   OPRD_RAT                Reviewed;         372 AA.
AC   P33533;
DT   01-FEB-1994, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1994, sequence version 1.
DT   02-OCT-2024, entry version 163.
DE   RecName: Full=Delta-type opioid receptor;
DE            Short=D-OR-1;
DE            Short=DOR-1;
DE   AltName: Full=Opioid receptor A;
GN   Name=Oprd1; Synonyms=Ror-a;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, SUBCELLULAR LOCATION, AND TISSUE
RP   SPECIFICITY.
RC   TISSUE=Brain;
RX   PubMed=8394245; DOI=10.1016/0014-5793(93)81011-n;
RA   Fukuda K., Kato S., Mori K., Nishi M., Takeshima H.;
RT   "Primary structures and expression from cDNAs of rat opioid receptor
RT   delta- and mu-subtypes.";
RL   FEBS Lett. 327:311-314(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, SUBCELLULAR LOCATION, AND TISSUE
RP   SPECIFICITY.
RC   STRAIN=Sprague-Dawley; TISSUE=Brain;
RX   PubMed=7519274; DOI=10.1002/jnr.490370605;
RA   Abood M.E., Noel M.A., Farnsworth J.S., Tao Q.;
RT   "Molecular cloning and expression of a delta-opioid receptor from rat
RT   brain.";
RL   J. Neurosci. Res. 37:714-719(1994).
CC   -!- FUNCTION: G-protein coupled receptor that functions as a receptor for
CC       endogenous enkephalins and for a subset of other opioids. Ligand
CC       binding causes a conformation change that triggers signaling via
CC       guanine nucleotide-binding proteins (G proteins) and modulates the
CC       activity of down-stream effectors, such as adenylate cyclase. Signaling
CC       leads to the inhibition of adenylate cyclase activity. Inhibits
CC       neurotransmitter release by reducing calcium ion currents and
CC       increasing potassium ion conductance. Plays a role in the perception of
CC       pain and in opiate-mediated analgesia. Plays a role in developing
CC       analgesic tolerance to morphine. {ECO:0000269|PubMed:7519274,
CC       ECO:0000269|PubMed:8394245}.
CC   -!- SUBUNIT: May form homooligomers. Forms a heterodimer with OPRM1.
CC       Interacts with GPRASP1. Interacts with RTP4; the interaction promotes
CC       cell surface localization of the OPRD1-OPRM1 heterodimer.
CC       {ECO:0000250|UniProtKB:P32300, ECO:0000250|UniProtKB:P41143}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:7519274,
CC       ECO:0000269|PubMed:8394245}; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:7519274, ECO:0000269|PubMed:8394245}.
CC   -!- TISSUE SPECIFICITY: Detected in brain, brain stem and brain cortex.
CC       {ECO:0000269|PubMed:7519274, ECO:0000269|PubMed:8394245}.
CC   -!- PTM: Ubiquitinated. A basal ubiquitination seems not to be related to
CC       degradation. Ubiquitination is increased upon formation of OPRM1:OPRD1
CC       oligomers leading to proteasomal degradation; the ubiquitination is
CC       diminished by RTP4. {ECO:0000250|UniProtKB:P32300}.
CC   -!- SIMILARITY: Belongs to the G-protein coupled receptor 1 family.
CC       {ECO:0000255|PROSITE-ProRule:PRU00521}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; D16348; BAA03851.1; -; mRNA.
DR   EMBL; U00475; AAA19939.1; -; mRNA.
DR   PIR; S34592; S34592.
DR   RefSeq; NP_036749.1; NM_012617.1.
DR   AlphaFoldDB; P33533; -.
DR   SMR; P33533; -.
DR   BioGRID; 246752; 1.
DR   STRING; 10116.ENSRNOP00000014084; -.
DR   BindingDB; P33533; -.
DR   ChEMBL; CHEMBL269; -.
DR   DrugCentral; P33533; -.
DR   GuidetoPHARMACOLOGY; 317; -.
DR   GlyCosmos; P33533; 2 sites, No reported glycans.
DR   GlyGen; P33533; 2 sites.
DR   iPTMnet; P33533; -.
DR   PhosphoSitePlus; P33533; -.
DR   PaxDb; 10116-ENSRNOP00000014084; -.
DR   Ensembl; ENSRNOT00000014084.4; ENSRNOP00000014084.2; ENSRNOG00000010531.4.
DR   Ensembl; ENSRNOT00055043589; ENSRNOP00055035580; ENSRNOG00055025285.
DR   Ensembl; ENSRNOT00060038284; ENSRNOP00060031562; ENSRNOG00060022110.
DR   Ensembl; ENSRNOT00065047858; ENSRNOP00065039267; ENSRNOG00065027771.
DR   GeneID; 24613; -.
DR   KEGG; rno:24613; -.
DR   UCSC; RGD:3233; rat.
DR   AGR; RGD:3233; -.
DR   CTD; 4985; -.
DR   RGD; 3233; Oprd1.
DR   eggNOG; KOG3656; Eukaryota.
DR   GeneTree; ENSGT00940000157669; -.
DR   HOGENOM; CLU_009579_8_1_1; -.
DR   InParanoid; P33533; -.
DR   OMA; SEARNKP; -.
DR   OrthoDB; 5393360at2759; -.
DR   PhylomeDB; P33533; -.
DR   TreeFam; TF315737; -.
DR   Reactome; R-RNO-375276; Peptide ligand-binding receptors.
DR   Reactome; R-RNO-418594; G alpha (i) signalling events.
DR   PRO; PR:P33533; -.
DR   Proteomes; UP000002494; Chromosome 5.
DR   Bgee; ENSRNOG00000010531; Expressed in frontal cortex and 2 other cell types or tissues.
DR   GO; GO:0043679; C:axon terminus; IDA:RGD.
DR   GO; GO:0032590; C:dendrite membrane; IDA:RGD.
DR   GO; GO:0016020; C:membrane; ISO:RGD.
DR   GO; GO:0043005; C:neuron projection; IBA:GO_Central.
DR   GO; GO:0098992; C:neuronal dense core vesicle; IDA:SynGO.
DR   GO; GO:0005886; C:plasma membrane; ISO:RGD.
DR   GO; GO:0098839; C:postsynaptic density membrane; IDA:SynGO.
DR   GO; GO:0045211; C:postsynaptic membrane; IDA:RGD.
DR   GO; GO:0042734; C:presynaptic membrane; IDA:SynGO.
DR   GO; GO:0097444; C:spine apparatus; IDA:SynGO.
DR   GO; GO:0030672; C:synaptic vesicle membrane; IDA:SynGO.
DR   GO; GO:0031982; C:vesicle; IDA:RGD.
DR   GO; GO:0038046; F:G protein-coupled enkephalin receptor activity; IDA:RGD.
DR   GO; GO:0004985; F:G protein-coupled opioid receptor activity; ISO:RGD.
DR   GO; GO:0042923; F:neuropeptide binding; IBA:GO_Central.
DR   GO; GO:0033612; F:receptor serine/threonine kinase binding; IPI:RGD.
DR   GO; GO:0007193; P:adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway; ISO:RGD.
DR   GO; GO:0008344; P:adult locomotory behavior; ISO:RGD.
DR   GO; GO:0071363; P:cellular response to growth factor stimulus; IEP:RGD.
DR   GO; GO:0071456; P:cellular response to hypoxia; ISO:RGD.
DR   GO; GO:0097237; P:cellular response to toxic substance; ISO:RGD.
DR   GO; GO:0042755; P:eating behavior; IMP:RGD.
DR   GO; GO:0038003; P:G protein-coupled opioid receptor signaling pathway; ISO:RGD.
DR   GO; GO:0007186; P:G protein-coupled receptor signaling pathway; ISO:RGD.
DR   GO; GO:0010629; P:negative regulation of gene expression; ISO:RGD.
DR   GO; GO:0031333; P:negative regulation of protein-containing complex assembly; ISO:RGD.
DR   GO; GO:0007218; P:neuropeptide signaling pathway; ISO:RGD.
DR   GO; GO:0007200; P:phospholipase C-activating G protein-coupled receptor signaling pathway; IDA:UniProtKB.
DR   GO; GO:0033138; P:positive regulation of peptidyl-serine phosphorylation; ISO:RGD.
DR   GO; GO:0051924; P:regulation of calcium ion transport; IMP:RGD.
DR   GO; GO:0051881; P:regulation of mitochondrial membrane potential; ISO:RGD.
DR   GO; GO:0045471; P:response to ethanol; IEP:RGD.
DR   GO; GO:0035094; P:response to nicotine; IEP:RGD.
DR   CDD; cd15089; 7tmA_Delta_opioid_R; 1.
DR   Gene3D; 1.20.1070.10; Rhodopsin 7-helix transmembrane proteins; 1.
DR   InterPro; IPR000321; Delta_opi_rcpt.
DR   InterPro; IPR000276; GPCR_Rhodpsn.
DR   InterPro; IPR017452; GPCR_Rhodpsn_7TM.
DR   InterPro; IPR001418; Opioid_rcpt.
DR   PANTHER; PTHR24229:SF2; DELTA-TYPE OPIOID RECEPTOR; 1.
DR   PANTHER; PTHR24229; NEUROPEPTIDES RECEPTOR; 1.
DR   Pfam; PF00001; 7tm_1; 1.
DR   PRINTS; PR00525; DELTAOPIOIDR.
DR   PRINTS; PR00237; GPCRRHODOPSN.
DR   PRINTS; PR00384; OPIOIDR.
DR   SMART; SM01381; 7TM_GPCR_Srsx; 1.
DR   SUPFAM; SSF81321; Family A G protein-coupled receptor-like; 1.
DR   PROSITE; PS00237; G_PROTEIN_RECEP_F1_1; 1.
DR   PROSITE; PS50262; G_PROTEIN_RECEP_F1_2; 1.
PE   2: Evidence at transcript level;
KW   Cell membrane; Disulfide bond; G-protein coupled receptor; Glycoprotein;
KW   Lipoprotein; Membrane; Palmitate; Receptor; Reference proteome; Transducer;
KW   Transmembrane; Transmembrane helix; Ubl conjugation.
FT   CHAIN           1..372
FT                   /note="Delta-type opioid receptor"
FT                   /id="PRO_0000069965"
FT   TOPO_DOM        1..47
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        48..75
FT                   /note="Helical; Name=1"
FT                   /evidence="ECO:0000250"
FT   TOPO_DOM        76..85
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        86..110
FT                   /note="Helical; Name=2"
FT                   /evidence="ECO:0000250"
FT   TOPO_DOM        111..122
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        123..144
FT                   /note="Helical; Name=3"
FT                   /evidence="ECO:0000250"
FT   TOPO_DOM        145..163
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        164..186
FT                   /note="Helical; Name=4"
FT                   /evidence="ECO:0000250"
FT   TOPO_DOM        187..206
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        207..238
FT                   /note="Helical; Name=5"
FT                   /evidence="ECO:0000250"
FT   TOPO_DOM        239..261
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        262..284
FT                   /note="Helical; Name=6"
FT                   /evidence="ECO:0000250"
FT   TOPO_DOM        285..299
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        300..321
FT                   /note="Helical; Name=7"
FT                   /evidence="ECO:0000250"
FT   TOPO_DOM        322..372
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250"
FT   REGION          340..372
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   LIPID           333
FT                   /note="S-palmitoyl cysteine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        18
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        33
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        121..198
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00521"
SQ   SEQUENCE   372 AA;  40450 MW;  F578BD1F64C61D50 CRC64;
     MEPVPSARAE LQFSLLANVS DTFPSAFPSA SANASGSPGA RSASSLALAI AITALYSAVC
     AVGLLGNVLV MFGIVRYTKL KTATNIYIFN LALADALATS TLPFQSAKYL METWPFGELL
     CKAVLSIDYY NMFTSIFTLT MMSVDRYIAV CHPVKALDFR TPAKAKLINI CIWVLASGVG
     VPIMVMAVTQ PRDGAVVCTL QFPSPSWYWD TVTKICVFLF AFVVPILIIT VCYGLMLLRL
     RSVRLLSGSK EKDRSLRRIT RMVLVVVGAF VVCWAPIHIF VIVWTLVDIN RRDPLVVAAL
     HLCIALGYAN SSLNPVLYAF LDENFKRCFR QLCRAPCGGQ EPGSLRRPRQ ATARERVTAC
     TPSDGPGGGA AA
//
